Quantitative assessment of the variation in IGF2BP2 gene and type 2 diabetes risk

Acta Diabetologica

Volumn 49, Issue 1 SUPPL., 2012, Pages

  Wu, Jie ^a   Wu, Junjie ^a,b   Zhou, Yuhao ^c   Zou, Houdong ^c   Guo, Shicheng ^b   Liu, Jie ^b   Lu, Liwen ^d   Xu, Hao ^e  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d Fengxian District Central Hospital of Shanghai   (China)

^e ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

IGF2BP2; Meta analysis; Susceptibility; Type 2 diabetes

Indexed keywords

AGE; ALLELE; ARTICLE; BODY MASS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DOMINANT GENE; ETHNICITY; GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IGF2BP2 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECESSIVE GENE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SYSTEMATIC REVIEW; ADULT; AGED; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MALE; META ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

IGF2BP2 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADULT; AGED; ALLELES; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA-BINDING PROTEINS;

EID: 84876552238     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0336-3     Document Type: Article

References (52)

1. van Tilburg J, van Haeften TW, Pearson P, Wijmenga C (2001) Defining the genetic contribution of type 2 diabetes mellitus. J Med Genet 38:569-578
2. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC (1999) A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19:1262-1270
3. Groenewoud MJ, Dekker JM, Fritsche A, Reiling E, Nijpels G, Heine RJ et al (2008) Variants of cdkal1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 51:1659-1663
4. Stroup DF, Berlin JA, Morton SC, MOOSE group et al (2000) Meta-analysis of observational studies in epidemiology, a proposal for reporting. JAMA 283:2008-2012
5. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
6. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253
7. Wen Y, Lu P, Dai L (2010) Association between resistin gene-420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis. Acta Diabetol doi: 10.1007/s00592-010-0247-8
8. Thompson SG, Sharp SJ (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18:2693-2708
9. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
10. Wagner M, Kunsch S, Duerschmied D, Beil M, Adler G, Mueller F, Gress TM (2003) Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas. Gastroenterology 124:1901-1914
11. Spagnoli FM, Brivanlou AH (2006) The RNA-binding protein, Vg1RBP, is required for pancreatic fate specification. Dev Biol 292:442-456
12. Groenewoud MJ, Dekker JM, Fritsche A, Reiling E, Nijpels G, Heine RJ, Maassen JA, Machicao F, Schafer SA, Haring HU et al (2008) Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 51:1659-1663
13. Palmer ND, Goodarzi MO, Langefeld CD, Ziegler J, Norris JM, Haffner SM, Bryer-Ash M, Bergman RN, Wagenknecht LE, Taylor KD et al (2008) Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the insulin resistance atherosclerosis family study. Diabetes 57:1093-1100
14. Ruchat SM, Elks CE, Loos RJ, Vohl MC, Weisnagel SJ, Rankinen T, Bouchard C, Perusse L (2008) Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetologia 46:217-226
15. Christiansen J, Kolte AM, Hansen TO, Nielsen FC (2009) Igf2 mrna-binding protein 2: Biological function and putative role in type 2 diabetes. J Mol Endocrinol 43:187-195
16. Doria A, Patti ME, Kahn CR (2008) The emerging genetic architecture of type 2 diabetes. Cell Metab 8:186-200
17. Rees SD, Hydrie MZ, Shera AS et al (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia 54:1368-1374
18. Rodriguez S, Eiriksdottir G, Gaunt TR, Harris TB, Launer LJ, Gudnason V, Day IN (2010) IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes. Growth Horm IGF Res 20:310-318
19. Shu XO, Long J, Cai Q et al (2010) Identification of new genetic risk variants for type 2 diabetes. PLoS Genet 6:e1001127
20. Chauhan G, Spurgeon CJ et al (2010) Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2 and CDKAL1 on the risk of type 2 diabetes in 5164 Indians. Diabetes 59:2068-2074
21. Tan JT, Ng DP, Nurbaya S, Seielstad M, Tai ES et al (2010) Polymorphisms identified through genome-wide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. J Clin Endocrinol Metab 95:390-397
22. Yamauchi T, Hara K, Maeda S et al (2010) A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet 42:864-868
23. Lin Y, Li P, Cai L et al (2010) Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population. BMC Med Genet 11:97
24. Wen J, Rönn T, Olsson A et al (2010) Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS One 5:e9153
25. Huang Q, Yin JY, Dai XP et al (2010) IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Acta Pharmacol Sin 31:709-717
26. Han X, Luo Y, Ren Q et al (2010) Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population. BMC Med Genet 11:81
27. Xu M, Bi Y, Xu Y et al (2010) Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS One 5:e14022
28. Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, Miki T, Kohara K, Makino H (2009) Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 58:493-498
29. Hu C, Zhang R, Wang C et al (2009) PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One 4:e7643
30. Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T et al (2009) Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 58:1690-1699
31. Wu Y, Li H, Loos RJ, Yu Z, Ye X, Chen L, Pan A, Hu FB, Lin X (2008) Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 57:2834-2842
32. Sanghera DK, Ortega L, Han S, Singh J, Ralhan SK, Wander GS, Mehra NK et al (2008) Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet 9:59
33. Rong R, Hanson RL, Ortiz D, Wiedrich C, Kobes S, Knowler WC, Bogardus C, Baier LJ (2009) Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 58:478-488
34. Bronstein M, Pisanté A, Yakir B, Darvasi A (2008) Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population. Hum Genet 124:101-104
35. Omori S, Tanaka Y, Takahashi A et al (2008) Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 57:791-795
36. Lee YH, Kang ES, Kim SH, Han SJ, Kim CH, Kim HJ, Ahn CW, Cha BS, Nam M, Nam CM, Lee HC (2008) Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet 53:991-998
37. Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y et al (2008) Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab 93:3136-3141
38. Ng MC, Park KS, Oh B, Tam CH, Cho YM et al (2008) Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6, 719 Asians. Diabetes 57:2226-2233
39. Lewis JP, Palmer ND, Hicks PJ, Sale MM, Langefeld CD, Freedman BI, Divers J, Bowden DW (2008) Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes 57:2220-2225
40. Lyssenko V, Jonsson A, Almgren P, Pulizzi N et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220-2232
41. van Hoek M, Dehghan A, Witteman JC et al (2008) Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 57:3122-3128
42. Herder C, Rathmann W, Strassburger K et al (2008) Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Horm Metab Res 40:722-726
43. Liu Y, Yu L, Zhang D et al (2008) Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia 51:2134-2137
44. Duesing K, Fatemifar G, Charpentier G et al (2008) Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians. Diabetes 57:1992-1996
45. Takeuchi F, Ochiai Y, Serizawa M et al (2008) Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q. J Hum Genet 53:314-324
46. Cauchi S, Meyre D, Durand E (2008) Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One 3:e2031
47. Grarup N, Rose CS, Andersson EA et al (2007) Studies of association of variants near the HHEX, CDKN2A/B and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10, 705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 56:3105-3111
48. Horikoshi M, Hara K, Ito C, Shojima N, Nagai R, Ueki K, Froguel P, Kadowaki T (2007) Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 50:2461-2466
49. Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336
50. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336-1341
51. Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345
52. Baier LJ, Hanson RL (2004) Genetic studies of the etiology of type 2 diabetes in Pima Indians: hunting for pieces to a complicated puzzle. Diabetes 53:1181-1186